BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 5605712)

  • 21. [Coronary and left ventricular dynamics of three substances with different beta-blocking effects: Propranolol, Pindolol, and Practolol].
    Moccetti T; Halter J; Lichtlen P
    Schweiz Med Wochenschr; 1972 Mar; 102(12):422-5. PubMed ID: 4401753
    [No Abstract]   [Full Text] [Related]  

  • 22. Contribution to the clinical evaluation of beta-adrenergic blocking drugs: 1-p-nitrophenyl-2-isopropylaminoethanol (INPEA) as an antagonist of catecholamines in normal persons and in coronary disease patients.
    Piva M; Ongari R
    Arzneimittelforschung; 1968 Feb; 18(2):179-88. PubMed ID: 5695376
    [No Abstract]   [Full Text] [Related]  

  • 23. [The pharmacodynamics of proxodolol when administered once and in a course of doses to patients with stenocardia of effort].
    Petrov IN; Rumiantsev AS; Smirnov MV
    Eksp Klin Farmakol; 1994; 57(3):54-7. PubMed ID: 7914123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical effect of beta receptor blockader in angina pectoris caused by coronary sclerosis].
    Schaller K
    Z Arztl Fortbild (Jena); 1970 Jul; 64(13):671-3. PubMed ID: 4398819
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical experience with the association of a beta-blocking agent and pentaerythrite].
    Barbi G; Tallone G
    Minerva Cardioangiol; 1969 Feb; 17(2):139-41. PubMed ID: 5777637
    [No Abstract]   [Full Text] [Related]  

  • 26. [Data on the effects of butydrine in patients with coronary insufficiency].
    De Maestri C; Rinaldi AR
    Minerva Cardioangiol; 1969 Feb; 17(2):142-50. PubMed ID: 5777638
    [No Abstract]   [Full Text] [Related]  

  • 27. [Phonomechanocardiography in patients treated with adrenergic beta blockaders].
    Mantykow JE; Lepera L; Slafer H; Conti LA
    Prensa Med Argent; 1969 Oct; 56(32):1556-60. PubMed ID: 4396852
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effects of beta adrenergic blockaders on the effort test in coronary insufficiency].
    Demiroglu C; Oztürk M
    Presse Med (1893); 1971 Apr; 79(17):765-6. PubMed ID: 4396515
    [No Abstract]   [Full Text] [Related]  

  • 29. [A new beta blocking agent: LB-46. Clinical use in the treatment of rhythm disorders and coronary insufficiency].
    Dutoit A; Lepoutre B; Leuridan B; Croccel L; Giard P
    J Sci Med Lille; 1972 Feb; 90(2):83-9. PubMed ID: 4403207
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effects of an adrenergic beta receptor blockader on exercise tolerance and myocardial function in patients with angina pectoris].
    De Petra V; Di Michele R; Cecchetti E
    Minerva Cardioangiol; 1973 Sep; 21(9):619-24. PubMed ID: 4745004
    [No Abstract]   [Full Text] [Related]  

  • 31. Beta adrenergic blocking agents for exertional angina pectoris.
    Thadani U
    Herz; 1982 Jun; 7(3):179-87. PubMed ID: 6124493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mechanisms of the hemodynamic effects of nonachlazine in ischemic heart disease patients].
    Zaslavskaia RM; Zolotaia RD; Olevskiĭ IKh; Duda SG; Vilkovyskiĭ FA
    Farmakol Toksikol; 1986; 49(6):73-7. PubMed ID: 3817152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
    Schnellbacher K; Bestehorn HP; Roskamm H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S201-7. PubMed ID: 11527130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of sorbonite on exercise tolerance in stable angina pectoris].
    Juszczyk Z
    Pol Tyg Lek; 1982 May; 37(11):301-4. PubMed ID: 7122293
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of strophanthin in adrenergic blockade on the blood supply and work of the heart in acute coronary artery occlusion].
    Sapozhkov AV; Verger DIa; Vakhrameev NIa
    Farmakol Toksikol; 1983; 46(1):42-5. PubMed ID: 6297963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effects of 3-(beta-diethylaminoethyl)-4-methyl-7-carbothoxymethoxy-2-oxo-(1,2-chromene)-hydrochloride and nitroglycerin on cardiovascular dynamics in healthy and coronary diseased hearts].
    Pippig L; Schneider KW
    Arzneimittelforschung; 1965 Sep; 15(9):1008-19. PubMed ID: 4955785
    [No Abstract]   [Full Text] [Related]  

  • 37. [Angina pectoris and blockade of beta-adrenergic receptors].
    Rivier JL
    Schweiz Med Wochenschr; 1967 Nov; 97(47):1564-7. PubMed ID: 5596883
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of k-strophanthin on hemodynamics and metabolism of the heart in coronary disease in rest and during angina pectoris induced by pacing].
    Klein WW; Brandt D; Pavek P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1646-50. PubMed ID: 347792
    [No Abstract]   [Full Text] [Related]  

  • 39. [Influence of beta-adrenergic block on cardiovascular function and on exercise tolerance in angina pectoris].
    Barbaresi F; Bacuzzi E; Manfredi M; Starcich R
    G Clin Med; 1966 Sep; 47(9):849-64. PubMed ID: 5994051
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of coronary insufficiency with beta-receptor antagonists (author's transl)].
    Hitzenberger G
    Arzneimittelforschung; 1977; 27(3a):700-2. PubMed ID: 17414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.